This study investigated heterogeneous subtypes of non-suicidal self-injury (NSSI) among college students and examined the psychosocial predictors of high-risk profiles to guide precision interventions ...
Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results